Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Jett

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Oncology|February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancerR F Marschke, J P Grill, J A Sloan, et al.
American Journal of Clinical Oncology|December 18, 1998
Phase II trial of topotecan for the treatment of mesotheliomaA W Maksymiuk, R F Marschke, H D Tazelaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapyV Liengswangwong, J A Bonner, E G Shaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trialA W Maksymiuk, J R Jett, J D Earle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancerC L Loprinzi, R M Goldberg, J Q Su, et al.
Journal of the National Cancer Institute|December 19, 1990
Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment groupR M Goldberg, J R Jett, T M Therneau, et al.
American Journal of Clinical Oncology|April 1, 1996
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lungE G Shaw, S Frytak, R T Eagan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lungJ S Robinow, E G Shaw, R T Eagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment GroupJ R Jett, L Everson, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancerJ R Jett, A W Maksymiuk, J Q Su, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancerR F Marschke, J P Grill, J A Sloan, et al.
American Journal of Clinical Oncology|December 18, 1998
Phase II trial of topotecan for the treatment of mesotheliomaA W Maksymiuk, R F Marschke, H D Tazelaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapyV Liengswangwong, J A Bonner, E G Shaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trialA W Maksymiuk, J R Jett, J D Earle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancerC L Loprinzi, R M Goldberg, J Q Su, et al.
Journal of the National Cancer Institute|December 19, 1990
Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment groupR M Goldberg, J R Jett, T M Therneau, et al.
American Journal of Clinical Oncology|April 1, 1996
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lungE G Shaw, S Frytak, R T Eagan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lungJ S Robinow, E G Shaw, R T Eagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment GroupJ R Jett, L Everson, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase III trial of recombinant interferon gamma in complete responders with small-cell lung cancerJ R Jett, A W Maksymiuk, J Q Su, et al.
Pageof 8